ESC Premium Access

Meet the Trialists - HPS3/TIMI55-REVEAL

Event: ESC CONGRESS 2017
Topic: Lipids (Epidemiology and Prevention)
Session type: Meet the Trialists
Date: 29 August 2017
Time: 10:35 - 10:55

Session

1 presentations in this session

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial.

Speaker: Professor M. Landray (Oxford, GB)
Thumbnail

1 speaker from this session

Professor Martin Landray

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk